M. Bozza et al., THE PACAP-TYPE I RECEPTOR AGONIST MAXADILAN FROM SAND FLY SALIVA PROTECTS MICE AGAINST LETHAL ENDOTOXEMIA BY A MECHANISM PARTIALLY DEPENDENT ON IL-10, European Journal of Immunology, 28(10), 1998, pp. 3120-3127
Sand fly saliva contains maxadilan, a peptide that causes vasodilation
and modifies the secretion of pro-inflammatory cytokines by macrophag
es. We show that 1 to 10 mu g maxadilan protected BALB/c mice against
a lethal dose of LPS. Maxadilan reduced serum levels of TNF-alpha by a
pproximately tenfold, while it caused a threefold increase in IL-6 and
IL-10. The protective effect of maxadilan is partially dependent on i
ts ability to induce IL-10 production since maxadilan did not prevent
death from endotoxic shock in IL-10(-/-) mice. Finally, maxadilan is a
selective agonist of the pituitary adenylate cyclase-activating pepti
de (PACAP) type I receptor, and we found that the natural ligand of th
is receptor (PACAP 38) also protected mice against lethal endotoxemia.
These results indicate that activation of the PACAP type I receptor m
ay contribute to the control of systemic inflammation by a mechanism t
hat is partially dependent on IL-10.